In this study we investigated the expression of the ATP2B genes in publicly available breast cancer gene expression datasets and studied the modulation of the expression of various Ca2+ pumps at the protein level by HDAC inhibitor and/or 17β-estradiol (E2) treatments in a variety of breast cancer cell lines. The gene discussed is ATP2A2; the disease is breast carcinoma.